These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 20814162)
1. Genetic variations in UDP-glucuronosyltransferase 2B7 gene (UGT2B7) in a Korean population. Hwang MS; Lee SJ; Jeong HE; Lee S; Yoo MA; Shin JG Drug Metab Pharmacokinet; 2010; 25(4):398-402. PubMed ID: 20814162 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms and haplotypes of the UDP-glucuronosyltransferase 2B7 gene promoter. Hu DG; Meech R; Lu L; McKinnon RA; Mackenzie PI Drug Metab Dispos; 2014 May; 42(5):854-62. PubMed ID: 24561451 [TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene. Innocenti F; Liu W; Fackenthal D; Ramírez J; Chen P; Ye X; Wu X; Zhang W; Mirkov S; Das S; Cook E; Ratain MJ Pharmacogenet Genomics; 2008 Aug; 18(8):683-97. PubMed ID: 18622261 [TBL] [Abstract][Full Text] [Related]
4. Genetic variations in UDP-glucuronosyltransferase 2B15 in a Korean population. Hwang MS; Lee SJ; Kim WY; Jeong HE; Shin JG Drug Metab Pharmacokinet; 2014; 29(1):105-9. PubMed ID: 23877107 [TBL] [Abstract][Full Text] [Related]
7. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. Holthe M; Rakvåg TN; Klepstad P; Idle JR; Kaasa S; Krokan HE; Skorpen F Pharmacogenomics J; 2003; 3(1):17-26. PubMed ID: 12629580 [TBL] [Abstract][Full Text] [Related]
8. Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen. Wang H; Yuan L; Zeng S Biochem Pharmacol; 2011 Dec; 82(11):1757-63. PubMed ID: 21856293 [TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in the 5'-flanking region of human UDP-glucuronosyltransferase 2B7 affect the Nrf2-dependent transcriptional regulation. Nakamura A; Nakajima M; Higashi E; Yamanaka H; Yokoi T Pharmacogenet Genomics; 2008 Aug; 18(8):709-20. PubMed ID: 18622263 [TBL] [Abstract][Full Text] [Related]
10. Homo- and hetero-dimerization of human UDP-glucuronosyltransferase 2B7 (UGT2B7) wild type and its allelic variants affect zidovudine glucuronidation activity. Yuan L; Qian S; Xiao Y; Sun H; Zeng S Biochem Pharmacol; 2015 May; 95(1):58-70. PubMed ID: 25770680 [TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Bhasker CR; McKinnon W; Stone A; Lo AC; Kubota T; Ishizaki T; Miners JO Pharmacogenetics; 2000 Nov; 10(8):679-85. PubMed ID: 11186130 [TBL] [Abstract][Full Text] [Related]
12. Identification of CYP19A1 single-nucleotide polymorphisms and their haplotype distributions in a Korean population. Lee SJ; Kim WY; Choi JY; Lee SS; Shin JG J Hum Genet; 2010 Mar; 55(3):189-93. PubMed ID: 20186154 [TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population. Saeki M; Saito Y; Jinno H; Tanaka-Kagawa T; Ohno A; Ozawa S; Ueno K; Kamakura S; Kamatani N; Komamura K; Kitakaze M; Sawada J Drug Metab Dispos; 2004 Sep; 32(9):1048-54. PubMed ID: 15319348 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism. Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168 [TBL] [Abstract][Full Text] [Related]
15. Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy. Hirota T; Ieiri I; Takane H; Sano H; Kawamoto K; Aono H; Yamasaki A; Takeuchi H; Masada M; Shimizu E; Higuchi S; Otsubo K Drug Metab Dispos; 2003 May; 31(5):677-80. PubMed ID: 12695358 [TBL] [Abstract][Full Text] [Related]
16. UGT2B7_-161C>T polymorphism is associated with lamotrigine concentration-to-dose ratio in a multivariate study. Blanca Sánchez M; Herranz JL; Leno C; Arteaga R; Oterino A; Valdizán EM; Nicolas JM; Adín J; Shushtarian M; Armijo JA Ther Drug Monit; 2010 Apr; 32(2):177-84. PubMed ID: 20216122 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of UGT1A9 and UGT2B7 nonsynonymous single nucleotide polymorphisms in West African, Papua New Guinean, and North American populations. Mehlotra RK; Bockarie MJ; Zimmerman PA Eur J Clin Pharmacol; 2007 Jan; 63(1):1-8. PubMed ID: 17115150 [TBL] [Abstract][Full Text] [Related]
18. Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients. Singkham N; Towanabut S; Lertkachatarn S; Punyawudho B Eur J Clin Pharmacol; 2013 Jun; 69(6):1285-91. PubMed ID: 23263737 [TBL] [Abstract][Full Text] [Related]
19. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935 [TBL] [Abstract][Full Text] [Related]
20. Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy. Božina N; Sporiš IŠ; Domjanović IK; Ganoci L; Šimičević L; Lovrić M; Romić ZČ; Gadže ŽP; Trkulja V Eur J Clin Pharmacol; 2023 Aug; 79(8):1117-1129. PubMed ID: 37340142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]